Abstracts

Abstract submission is now open.

SUBMISSION DEADLINE: Friday, August 1, 2025

NOTIFICATION DATE: Friday, August 8, 2025

Fee: No fee for non-industry-sponsored abstracts; $495 per abstract for industry-sponsored abstracts.

At least one (1) author (or representative) must be registered for the in-person meeting to have their abstracts considered for poster display.

All accepted abstratcs will be displayed at the 26th Annual Las Vegas Dermatology Seminar, Spetember 11-13, 2025, to be held at the Fontainebleau Las Vegas, Nevada. Encore posters are welcome.

Submit Abstract

If you are returning to complete or check the status of your submission, please sign-in using your email address and password.

Topics

We invite all registered meeting attendees to submit abstracts for posters of their latest research on the following topics:

Acne & Rosacea
Atopic Dermatitis
Cutaneous Malignancies
Other Dermatology Topics (Alopecia Areata, Hidradenitis Suppurativa, Hyperpigmentation, Nails Diseases, etc.)

See Guidelines

Submission Rules

At least one (1) author (or representative) must be registered for the in-person meeting to have their abstracts considered for poster display.

Encore posters are welcome.

Get Read by QxMD

In addition, approved abstracts will also be submitted and indexed through our partner brand Read by QxMD.

The platform drives awareness, dissemination and engagement with this content via the Read by QxMD platform, as an educational tactic to drive CQI. ‘Read’ works on iPhone, iPad, Android smartphones & tablets and any web-enabled device (including desktops), and uses channels such as mobile, email and push notification to connect with our global community of healthcare providers and researchers.

Download the App

Abstract Formatting and Content Guidelines

Language

English

Font

Ariel

Authors

Full last name, first name, affiliations, degrees and contact information

BOLD the name of the Presenting Author and include the Presenting Author’s contact information

The author's disclosures must be included to be included to be accepted

Please ensure that your email address is accurate, as all correspondence will be sent via email

Character Count

Maximum of 3000 characters, including spaces
(not including the title, authors, or affiliations)

Section Structure

A “structured abstract” format is preferred.
Sections marked as: Background, Objectives, Methods, Results, and Conclusions

Citations

References must be included as parenthetical in-text citations: first author, et al. Journal and year
(eg, Cruz D, et al. Blood 2012)  

Figure and Table Count

Maximum of 2 relevant tables or figures
Submit images as attachments and reference figure or table as an in-text citation
(do not embed in the Word Document file.)

Image File Format

jpg

Image File Resolution

600 dpi

Abstracts containing non-generic drug names, personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted

Please note that abstracts will not be accepted if any author’s disclosures are not missing.